ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Fuel Cycle & Waste Management
Devoted to all aspects of the nuclear fuel cycle including waste management, worldwide. Division specific areas of interest and involvement include uranium conversion and enrichment; fuel fabrication, management (in-core and ex-core) and recycle; transportation; safeguards; high-level, low-level and mixed waste management and disposal; public policy and program management; decontamination and decommissioning environmental restoration; and excess weapons materials disposition.
Meeting Spotlight
Conference on Nuclear Training and Education: A Biennial International Forum (CONTE 2025)
February 3–6, 2025
Amelia Island, FL|Omni Amelia Island Resort
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jan 2025
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
February 2025
Nuclear Technology
Fusion Science and Technology
Latest News
Let it RAIN: A new approach to radiation communication
Despite its significant benefits, the public perception of radiation is generally negative due to its inherent nature: it is ubiquitous yet cannot be seen, heard, smelled, or touched—as if it were a ghost roaming around uncensored. The public is frightened of this seemingly creepy phantom they cannot detect with their senses. This unfounded fear has hampered the progress of the nuclear industry and radiation professions.
Natalie Baughan, Alexis Poitrasson-Rivière, Jonathan B. Moody, Benjamin C. Lee, Edward P. Ficaro
Nuclear Technology | Volume 206 | Number 7 | July 2020 | Pages 977-983
Technical Paper – Special section on the 2019 ANS Student Conference | doi.org/10.1080/00295450.2019.1708142
Articles are hosted by Taylor and Francis Online.
Traditional patient selection criteria for cardiac resynchronization therapy (CRT) could be improved to predict patient response to CRT. Assessment of cardiac dyssynchrony using gated myocardial perfusion single-photon emission computed tomography (SPECT) or positron emission tomography (PET) in quantification software programs can be a reliable alternative. Quantitative parameters that describe the left ventricular phase analysis histogram such as phase standard deviation, bandwidth, and entropy aid in physician decision making. Entropy has been found in previous studies to be an effective parameter in identifying patients with left ventricular cardiac dyssynchrony. In this paper, we describe the characteristics of the entropy parameter with respect to other parameters such as phase standard deviation and histogram bandwidth. The implementation and testing of the entropy metric in the Corridor4DM (4DM) software package is also described. Algorithm testing and characterization were performed using computer-generated pseudorandom normal distributions. Implementation testing in 4DM was performed with two groups of patient data: patients with a left bundle branch block (LBBB) and patients with low pretest likelihood (LLk) for coronary artery disease. Entropy was found to monotonically increase in a semilogarithmic fashion with respect to phase standard deviation. For pseudorandom normal distributions with a constant standard deviation, the number of histogram bins used in calculating the entropy metric varied the metric by up to 61.3%; on average, an increase in histogram bins from 60 to 100 increased the mean entropy value by 11.0%. Implementation testing in 4DM showed agreement with the preliminary algorithm results and found a clear separation in entropy values between LLk and LBBB patients.